PFG Investments LLC Purchases New Holdings in DocuSign, Inc. (NASDAQ:DOCU)

PFG Investments LLC purchased a new stake in DocuSign, Inc. (NASDAQ:DOCU - Free Report) in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 14,619 shares of the company's stock, valued at approximately $871,000.

Several other hedge funds have also made changes to their positions in the company. New York State Teachers Retirement System lifted its position in DocuSign by 0.9% in the 4th quarter. New York State Teachers Retirement System now owns 18,282 shares of the company's stock worth $1,087,000 after buying an additional 163 shares in the last quarter. Tokio Marine Asset Management Co. Ltd. lifted its position in DocuSign by 2.7% in the 4th quarter. Tokio Marine Asset Management Co. Ltd. now owns 6,975 shares of the company's stock worth $415,000 after buying an additional 184 shares in the last quarter. Whittier Trust Co. lifted its position in DocuSign by 28.8% in the 4th quarter. Whittier Trust Co. now owns 935 shares of the company's stock worth $56,000 after buying an additional 209 shares in the last quarter. Mitsubishi UFJ Asset Management Co. Ltd. lifted its position in DocuSign by 0.3% in the 4th quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 83,899 shares of the company's stock worth $4,617,000 after buying an additional 239 shares in the last quarter. Finally, SeaCrest Wealth Management LLC lifted its position in DocuSign by 2.2% in the 1st quarter. SeaCrest Wealth Management LLC now owns 11,327 shares of the company's stock worth $675,000 after buying an additional 240 shares in the last quarter. Hedge funds and other institutional investors own 77.64% of the company's stock.

Insider Activity at DocuSign

In related news, CEO Allan C. Thygesen sold 7,680 shares of DocuSign stock in a transaction dated Thursday, February 1st. The shares were sold at an average price of $61.27, for a total transaction of $470,553.60. Following the completion of the transaction, the chief executive officer now directly owns 111,767 shares of the company's stock, valued at approximately $6,847,964.09. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. In other DocuSign news, Director Teresa Briggs sold 499 shares of the business's stock in a transaction dated Thursday, February 29th. The shares were sold at an average price of $52.99, for a total value of $26,442.01. Following the completion of the transaction, the director now directly owns 6,169 shares of the company's stock, valued at $326,895.31. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, CEO Allan C. Thygesen sold 7,680 shares of the business's stock in a transaction dated Thursday, February 1st. The stock was sold at an average price of $61.27, for a total transaction of $470,553.60. Following the completion of the transaction, the chief executive officer now directly owns 111,767 shares of the company's stock, valued at $6,847,964.09. The disclosure for this sale can be found here. Insiders sold 54,871 shares of company stock valued at $3,176,199 in the last ninety days. Insiders own 17.80% of the company's stock.

Analyst Ratings Changes

Several brokerages have recently commented on DOCU. JMP Securities restated a "market outperform" rating and set a $84.00 price target on shares of DocuSign in a research note on Friday, April 12th. Royal Bank of Canada restated a "sector perform" rating and set a $59.00 price target on shares of DocuSign in a research note on Friday, April 12th. Needham & Company LLC restated a "hold" rating on shares of DocuSign in a research note on Friday, April 12th. UBS Group upgraded shares of DocuSign from a "sell" rating to a "neutral" rating and increased their price target for the stock from $48.00 to $62.00 in a research note on Friday, April 12th. Finally, Wells Fargo & Company lowered their target price on shares of DocuSign from $55.00 to $45.00 and set an "underweight" rating on the stock in a research note on Monday, February 5th. Two equities research analysts have rated the stock with a sell rating, seven have issued a hold rating and two have issued a buy rating to the company's stock. Based on data from MarketBeat, the stock presently has an average rating of "Hold" and a consensus target price of $60.25.

DocuSign Stock Performance

Shares of NASDAQ:DOCU traded down $0.15 during midday trading on Friday, reaching $57.20. 1,117,148 shares of the company's stock were exchanged, compared to its average volume of 1,479,879. The company's 50 day simple moving average is $56.49 and its two-hundred day simple moving average is $52.80. The firm has a market capitalization of $11.75 billion, a PE ratio of 158.89, a price-to-earnings-growth ratio of 4.94 and a beta of 0.89. DocuSign, Inc. has a 12 month low of $38.11 and a 12 month high of $64.76.

DocuSign (NASDAQ:DOCU - Get Free Report) last released its quarterly earnings data on Thursday, March 7th. The company reported $0.15 EPS for the quarter, topping analysts' consensus estimates of $0.09 by $0.06. The company had revenue of $712.39 million during the quarter, compared to the consensus estimate of $698.05 million. DocuSign had a net margin of 2.68% and a return on equity of 13.91%. On average, research analysts anticipate that DocuSign, Inc. will post 0.87 earnings per share for the current year.

DocuSign Profile

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.